Literature DB >> 373817

Two populations of granulocytes in paroxysmal nocturnal hemoglobinuria.

M Stern, W F Rosse.   

Abstract

The granulocytes in paroxysmal nocturnal hemoglobinuria (PNH) are defective, and the defect is similar to that previously described for the PNH erythrocyte. Using anti-I antibody to activate complement and 51Cr release to detect cell lysis, we found two populations of granulocytes that differed in their susceptibility to lysis by complement in 5 of 6 patients. A proportion of the cells were lysed by one-fifteenth to one-twentieth the amount of complement required to lyse normal cells; the remainder of the granulocytes appeared to be normal in their susceptibility to the lytic action of complement. The binding of the third component of complement (C3) to PNH granulocytes was at least twice that bound to normal cells, even though the binding of antibody was the same for normal and PNH cells. This suggests that the binding of C3 and probably the efficiency of the terminal steps of complement lysis are increased in the abnormal PHN granulocyte. These defects affect only a portion of the granulocytes, thus suggesting that the disorder is a clonal stem cell abnormality.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 373817

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  [Paroxysmal nocturnal hemoglobinuria].

Authors:  P Blaas; S Weber; G M Hänsch; H H Peter
Journal:  Klin Wochenschr       Date:  1990-03-05

2.  Abnormality of glycophorin-alpha on paroxysmal nocturnal hemoglobinuria erythrocytes.

Authors:  C J Parker; C M Soldato; W F Rosse
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

3.  Paroxysmal nocturnal haemoglobinuria.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-13

4.  Paroxysmal nocturnal hemoglobinuria--present status and future prospects.

Authors:  W F Rosse
Journal:  West J Med       Date:  1980-03

5.  Presence of the Tn antigen on hematopoietic progenitors from patients with the Tn syndrome.

Authors:  W Vainchenker; G Vinci; U Testa; A Henri; A Tabilio; M P Fache; H Rochant; J P Cartron
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Activation of human complement by immunoglobulin G antigranulocyte antibody.

Authors:  P K Rustagi; M S Currie; G L Logue
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

7.  Clonal expression of the Tn antigen in erythroid and granulocyte colonies and its application to determination of the clonality of the human megakaryocyte colony assay.

Authors:  W Vainchenker; U Testa; J F Deschamps; A Henri; M Titeux; J Breton-Gorius; H Rochant; D Lee; J P Cartron
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

8.  Increased expression of complement decay-accelerating factor during activation of human neutrophils.

Authors:  M Berger; M E Medof
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

Review 9.  Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.

Authors:  T Kinoshita; M E Medof; R Silber; V Nussenzweig
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.